Showing results (51-60 of 82) with videos related to
Sort By:
Pageof 9
Journal of the Pediatric Infectious Diseases Society|June 14, 2019
Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based TreatmentNikki Higa, Amy Pelz, Donald Birch, et al.The Pediatric Infectious Disease Journal|December 19, 2013
Population pharmacokinetics of intravenous acyclovir in preterm and term infantsMario R Sampson, Barry T Bloom, Robert W Lenfestey, et al.Clinical Pharmacokinetics|September 22, 2023
Cannabidiol Exposure Through Maternal Marijuana Use: Predictions in Breastfed InfantsCindy H T Yeung, Kerri A Bertrand, Brookie M Best, et al.AIDS (London, England)|September 22, 2006
Reduced lopinavir exposure during pregnancyAlice M Stek, Mark Mirochnick, Edmund Capparelli, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2025
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir StudyTim R Cressey, Nicolas Salvadori, Helena Rabie, et al.The Journal of Antimicrobial Chemotherapy|February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modellingStein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.BMJ Open|July 6, 2019
Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trialSharana Mahomed, Nigel Garrett, Edmund Capparelli, et al.The Pediatric Infectious Disease Journal|May 11, 2010
A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in ThailandNirun Vanprapar, Tim R Cressey, Kulkanya Chokephaibulkit, et al.Archives of Neurology|January 16, 2008
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous systemScott Letendre, Jennifer Marquie-Beck, Edmund Capparelli, et al.The Lancet. HIV|July 17, 2019
Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research prioritiesSharon Nachman, Claire L Townsend, Elaine J Abrams, et al.Pageof 9